A detailed history of Rockefeller Capital Management L.P. transactions in Pfizer Inc stock. As of the latest transaction made, Rockefeller Capital Management L.P. holds 1,630,089 shares of PFE stock, worth $40.7 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares
1,630,089
Previous 1,597,565 2.04%
Holding current value
$40.7 Million
Previous $44.7 Million 5.54%
% of portfolio
0.13%
Previous 0.13%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$27.7 - $31.39 $900,914 - $1.02 Million
32,524 Added 2.04%
1,630,089 $47.2 Million
Q2 2024

Aug 12, 2024

SELL
$25.26 - $29.6 $3.37 Million - $3.95 Million
-133,551 Reduced 7.71%
1,597,565 $44.7 Million
Q1 2024

May 14, 2024

SELL
$25.89 - $29.73 $13.4 Million - $15.4 Million
-517,866 Reduced 23.03%
1,731,116 $48 Million
Q4 2023

Feb 14, 2024

BUY
$26.13 - $33.94 $1.15 Million - $1.49 Million
43,846 Added 1.99%
2,248,982 $64.7 Million
Q3 2023

Nov 14, 2023

BUY
$32.09 - $37.51 $3.89 Million - $4.54 Million
121,124 Added 5.81%
2,205,136 $73.1 Million
Q2 2023

Aug 14, 2023

BUY
$36.12 - $41.79 $3.01 Million - $3.48 Million
83,329 Added 4.17%
2,084,012 $76.4 Million
Q1 2023

May 17, 2023

SELL
$39.39 - $51.28 $2.36 Million - $3.07 Million
-59,831 Reduced 2.9%
2,000,683 $81.6 Million
Q4 2022

Mar 06, 2023

BUY
$41.75 - $54.5 $22.9 Million - $29.9 Million
547,851 Added 36.22%
2,060,514 $106 Million
Q3 2022

Nov 02, 2022

BUY
$43.76 - $53.42 $3.59 Million - $4.38 Million
82,082 Added 5.74%
1,512,663 $66.2 Million
Q2 2022

Aug 12, 2022

BUY
$46.53 - $55.17 $7.42 Million - $8.8 Million
159,498 Added 12.55%
1,430,581 $75 Million
Q1 2022

May 13, 2022

BUY
$45.75 - $56.69 $5.65 Million - $7 Million
123,492 Added 10.76%
1,271,083 $65.8 Million
Q4 2021

Feb 14, 2022

BUY
$41.32 - $61.25 $1.09 Million - $1.61 Million
26,269 Added 2.34%
1,147,591 $67.8 Million
Q3 2021

Nov 12, 2021

BUY
$39.25 - $50.42 $5.54 Million - $7.11 Million
141,066 Added 14.39%
1,121,322 $48.2 Million
Q2 2021

Aug 10, 2021

BUY
$35.91 - $40.68 $3.63 Million - $4.11 Million
101,059 Added 11.49%
980,256 $38.4 Million
Q1 2021

May 11, 2021

SELL
$33.49 - $37.77 $512,865 - $578,409
-15,314 Reduced 1.71%
879,197 $31.9 Million
Q4 2020

Feb 12, 2021

BUY
$33.47 - $42.56 $5.05 Million - $6.42 Million
150,834 Added 20.28%
894,511 $32.9 Million
Q3 2020

Nov 13, 2020

BUY
$31.75 - $37.25 $2.17 Million - $2.55 Million
68,483 Added 10.14%
743,677 $27.3 Million
Q2 2020

Aug 12, 2020

SELL
$30.12 - $36.54 $2.7 Million - $3.27 Million
-89,540 Reduced 11.71%
675,194 $22.1 Million
Q1 2020

May 12, 2020

BUY
$27.03 - $38.62 $6.78 Million - $9.69 Million
250,796 Added 48.8%
764,734 $25 Million
Q4 2019

Feb 07, 2020

BUY
$32.92 - $37.36 $3.25 Million - $3.69 Million
98,770 Added 23.79%
513,938 $20.1 Million
Q3 2019

Nov 12, 2019

BUY
$32.49 - $42.13 $3.89 Million - $5.04 Million
119,612 Added 40.47%
415,168 $14.9 Million
Q2 2019

Aug 09, 2019

BUY
$36.98 - $41.52 $836,524 - $939,223
22,621 Added 8.29%
295,556 $12.8 Million
Q1 2019

May 10, 2019

BUY
$37.5 - $41.2 $4.41 Million - $4.85 Million
117,609 Added 75.72%
272,935 $11.6 Million
Q4 2018

Feb 12, 2019

BUY
$38.47 - $43.86 $1.31 Million - $1.49 Million
34,080 Added 28.11%
155,326 $6.78 Million
Q3 2018

Nov 02, 2018

BUY
$34.47 - $41.81 $296,855 - $360,067
8,612 Added 7.65%
121,246 $5.34 Million
Q2 2018

Jul 31, 2018

SELL
$32.98 - $35.16 $484,937 - $516,992
-14,704 Reduced 11.55%
112,634 $4.09 Million
Q1 2018

May 09, 2018

BUY
$31.91 - $37.02 $4.06 Million - $4.71 Million
127,338 New
127,338 $4.52 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $140B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Rockefeller Capital Management L.P. Portfolio

Follow Rockefeller Capital Management L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rockefeller Capital Management L.P., based on Form 13F filings with the SEC.

News

Stay updated on Rockefeller Capital Management L.P. with notifications on news.